$AIMD

chiang yao-chung purchased $4K of AIMD (indirect holdings)

chiang yao-chung purchased 2,000 indirectly-held shares of Ainos, Inc. (AIMD) at $2.00 on 2026-05-27.

Original reporting
SEC EDGAR · chiang yao-chung
Published May 29, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 29, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIMD
Bullish
medium confidence
Mentioned
$AIMD
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIMDBullishLow
01

Why it matters

The disclosure adds a datapoint on insider behavior but does not include operational, financial, or regulatory catalysts.

02

Market read

Traders may note mild sentiment support, but the transaction is small and lacks additional fundamental context.

03

What to watch

The filing does not disclose rationale, and the purchase size ($4,000) is too small to materially change expectations.

Relevance 6/10Novelty 6/10Timing: Filed 2026-05-29 for a 2026-05-27 purchase

Background

The article is an SEC EDGAR Form 4 disclosure of an insider (director) open-market purchase in Ainos, Inc.

Company-level read

Ticker impact

$AIMDBullishMedium confidence
Context

Ainos director bought 2,000 shares in an open-market transaction at $2.00/share, disclosed via SEC Form 4.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and small.

Evidence & confidence

This is an SEC Form 4 insider transaction with a small value ($4,000) and no 10b5-1 plan, which can be read as supportive but is not a material corporate event.

Market effects

No sector-wide read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Small, non-10b5-1 insider buys can be routine personal liquidity/portfolio actions rather than a strong conviction signal.

Key entities

  • Ainos, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • chiang yao-chung

    Director who purchased 2,000 shares on 2026-05-27.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIMDHigh

Ainos Shares Rise 6.9% After Receiving Initial AI Nose Semiconductor Orders

Ainos Inc. (AIMD) shares rose 6.9% after receiving initial commercial orders for its AI Nose platform from a semiconductor manufacturer. The orders follow validation activities and represent a shift to commercial deployment. The company expects revenue from these orders in the second half of 2026. Ainos also reported its chemical dataset has surpassed one billion records, up from 878 million in August.

$AIMDHigh

Ainos stock jumps on AI Nose orders from semiconductor sector

Ainos Inc (AIMD) shares rose 6.9% premarket after receiving initial commercial orders for its AI Nose platform from a semiconductor manufacturer. The orders mark a shift to commercial deployment, with revenue expected from late 2026. The company also announced its real-world chemical dataset surpassed 1 billion records, up from 878 million in August. AIMD's technology is used in semiconductor manufacturing for chemical perception and data collection.

$AIMDLow

Ainos, Inc. (AIMD): Results of Operations and Financial Condition

Ainos, Inc. (AIMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) (“Ainos” or the “Company”) today announced results for the second quarter en

$AIMDMed

Ainos, Inc.: VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

Ainos, Inc. (NASDAQ:AIMD) said VASRO GmbH highlighted its AI Nose platform’s expansion into live emergency department operations. VASRO reports a research program at an Asia academic medical center to generate 2,500+ hours of emergency-department environmental scent data for overcrowding early warning and respiratory infection risk analysis. The initiative broadens evaluations beyond industrial settings and supports Ainos’ Smell Language Model development.